TrialJournal of immunology (Baltimore, Md. : 1950)2004

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.

Paul F Robbins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.